Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

Canadian Cancer Trials Group IND.195 -- A Phase II Study of SB939 in Patients with Recurrent or Metastatic Castration Resistant Prostate Cancer -- was centrally activated 10 February 2010.